KLRA
KLRA
US4829311020
Kailera Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
1.51B EUR
2.86B EUR
Enterprise Value
389.91M EUR
2.74B EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-2.7x
--
Price to Sales
--
--
Price to Book
1.35x
2.55x
EV/Revenue
--
--
EV/EBITDA
-1.25x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-6.66%
ende